AI Researchers Smoking to Signal Faith in AI Cancer Cure, Palantir CTO Shyam Sankar Claims

Palantir CTO Reveals Bizarre Smoking Trend Among AI Researchers

Shyam Sankar, Palantir CTO, made a startling claim during his October 11 interview on CBS Face the Nation: AI researchers have started smoking to signal their unwavering faith in AI1

1

. According to Sankar, these researchers believe so strongly that AI will cure cancer that they're willing to risk their health as a symbolic gesture. "So many AI researchers have started smoking as a way of signaling to other researchers how much they believe in AI," Sankar explained to a visibly confused host Margaret Brennan1

1

. The logic, he stated, follows this reasoning: "I believe so much in AI that it's going to cure cancer. So I'm showing you my chips are all in"2

2

.

Mass Psychosis and the Machine God of Silicon Valley

Sankar didn't hold back in his criticism, describing this behavior as mass psychosis and social delusion that's derailing substantive discussions about AI's actual state and capabilities1

1

. The Palantir Technologies executive pointed to what he called an "unseen force" driving AI narratives: the effective altruism movement, which he characterized as a "millenarian doomsday cult meets messianic complex"1

1

. Drawing on Pascal's observation about a God-shaped hole in every human heart, Sankar argued that Silicon Valley workers have filled that void with what he termed the machine God of AGI2

2

. He noted that roughly 2,000 AI researchers in America subscribe to this worldview around effective altruism, creating a culture where techno-optimism has morphed into something resembling religious faith1

1

.

The Dangerous Math Behind the Bet

The health implications of this wager are starkly lopsided. Smoking causes more than 480,000 deaths annually in the United States, making it the leading preventable cause of disease and death according to the Centers for Disease Control and Prevention4

4

. A former cancer researcher speaking to The Register warned about the impracticality of this approach, noting that "even with AI, developing and introducing a new cancer drug into any of the world's health systems can take several years"1

1

. The researcher added concerns about drug resistance developing in tumors, further complicating any potential cure. Google DeepMind CEO Demis Hassabis predicted that 2025 would bring AI-designed pills to market, yet that milestone hasn't materialized1

1

.

AI Ethics and the Effective Altruism Debate

Sankar's critique extends beyond smoking to broader concerns about AI regulation and existential risks. He argued that effective altruism's focus on long-term AI safety has spawned excessive doomerism in Silicon Valley1

1

. This philosophical movement prioritizes decisions that benefit the maximum number of humans over the longest timeframe, leading adherents to contemplate far-fetched scenarios about AI threatening humanity. Recent warnings from Anthropic employee Jacob Coxon, who claimed "there is a substantial probability that this technology could kill everyone," exemplify the doomsday cult mentality Sankar criticizes5

5

. Sankar believes these theological rather than technical critiques distract from practical AI development and deployment.

Reality Check on AI Medical Breakthroughs

While AI shows promise in healthcare, tangible breakthroughs remain limited. Moderna and Merck announced progress in August on a melanoma vaccine trial involving 1,100 patients, where AI analyzed tumor samples to create personalized treatments5

5

. Dr. David Fajgenbaum, co-founder of AI-driven nonprofit Every Cure, explained that AI's advantage lies in analyzing vast datasets across decades of research5

5

. However, smoking causes multiple cancer types and numerous non-cancerous fatal conditions, making any single cure insufficient protection2

2

. The timeline for clinical trials and regulatory approval means even successful AI-discovered treatments take years to reach patients.

Implications for Palantir and AI Investment

For investors in Palantir Technologies, trading around $208.81 following Sankar's comments, the irony is notable: a top executive at an AI beneficiary company warning about delusion surrounding the technology4

4

. This aligns with Palantir's positioning as a practical AI implementation company focused on measurable results for governments and corporations. Sankar's prescription emphasizes proving AI can strengthen national prosperity and security while building safety into products from the start4

4

. Watch whether this internal critique affects how investors separate business fundamentals from hype-driven valuations in the AI sector. The broader question remains whether Silicon Valley's culture of bold predictions serves innovation or creates dangerous social delusion that encourages reckless personal decisions in the name of technological faith.